144 related articles for article (PubMed ID: 21566772)
1. Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.
Varshosaz J; Ahmadi F; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
Int J Prev Med; 2010; 1(2):115-23. PubMed ID: 21566772
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat.
Varshosaz J; Ahmadi F; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
J Microencapsul; 2011; 28(1):62-73. PubMed ID: 21171817
[TBL] [Abstract][Full Text] [Related]
4. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.
Varshosaz J; Emami J; Fassihi A; Tavakoli N; Minaiyan M; Ahmadi F; Mahzouni P; Dorkoosh F
Int J Colorectal Dis; 2010 Oct; 25(10):1159-65. PubMed ID: 20669022
[TBL] [Abstract][Full Text] [Related]
7. Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat.
Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Rahmani N; Dorkoosh F; Mahzouni P
Iran J Pharm Res; 2012; 11(3):733-45. PubMed ID: 24250500
[TBL] [Abstract][Full Text] [Related]
8. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
[TBL] [Abstract][Full Text] [Related]
9. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
10. Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment.
Zhang Y; Wang L; Wang ZD; Zhou Q; Zhou X; Zhou T; Guan YX; Liu X
J Nanobiotechnology; 2023 May; 21(1):145. PubMed ID: 37127609
[TBL] [Abstract][Full Text] [Related]
11. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
Patel NV; Patel JK; Shah SH; Patel JN
Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
[TBL] [Abstract][Full Text] [Related]
13. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E
Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Budesonide-Hydroxypropyl-β-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis.
Lázaro CM; de Oliveira CC; Gambero A; Rocha T; Cereda CMS; de Araújo DR; Tofoli GR
Dig Dis Sci; 2020 Nov; 65(11):3297-3304. PubMed ID: 31974913
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).
Fellermann K; Schiefke I; Rácz I; Derova J; Jonaitis L; Wehrum S; Nacak T; Greinwald R
United European Gastroenterol J; 2020 Dec; 8(10):1186-1195. PubMed ID: 33028169
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis.
Ferri D; Costero AM; Gaviña P; Parra M; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
Int J Pharm; 2019 Apr; 561():93-101. PubMed ID: 30817986
[TBL] [Abstract][Full Text] [Related]
17. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model.
Qelliny MR; Aly UF; Elgarhy OH; Khaled KA
AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601
[TBL] [Abstract][Full Text] [Related]
18. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice.
Gareb B; Dijkstra G; Kosterink JGW; Frijlink HW
Int J Pharm; 2019 Jan; 554():366-375. PubMed ID: 30414898
[TBL] [Abstract][Full Text] [Related]
19. A budesonide prodrug accelerates treatment of colitis in rats.
Cui N; Friend DR; Fedorak RN
Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
[TBL] [Abstract][Full Text] [Related]
20. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]